BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10822130)

  • 1. Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential.
    Sato N; Mizumoto K; Beppu K; Maehara N; Kusumoto M; Nabae T; Morisaki T; Katano M; Tanaka M
    Cancer Lett; 2000 Jul; 155(2):153-61. PubMed ID: 10822130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-RII influences the prognosis of pancreatic cancer.
    Büchler P; Reber HA; Büchler MW; Friess H; Hines OJ
    Ann Surg; 2002 Dec; 236(6):738-49; discussion 749. PubMed ID: 12454512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
    Fukasawa M; Korc M
    Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel nude mouse model of liver metastasis and peritoneal dissemination from the same human pancreatic cancer line.
    Nishimori H; Yasoshima T; Hata F; Denno R; Yanai Y; Nomura H; Tanaka H; Kamiguchi K; Sato N; Hirata K
    Pancreas; 2002 Apr; 24(3):242-50. PubMed ID: 11893931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.
    Fralix KD; Ahmed MM; Mattingly C; Swiderski C; McGrath PC; Venkatasubbarao K; Kamada N; Mohiuddin M; Strodel WE; Freeman JW
    Cancer; 2000 May; 88(9):2010-21. PubMed ID: 10813711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity.
    Aoki K; Yoshida T; Sugimura T; Terada M
    Cancer Res; 1995 Sep; 55(17):3810-6. PubMed ID: 7641198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype.
    Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
    Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
    Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis.
    McElroy MK; Kaushal S; Tran Cao HS; Moossa AR; Talamini MA; Hoffman RM; Bouvet M
    Mol Cancer Ther; 2009 Jul; 8(7):1779-86. PubMed ID: 19584238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of SUIT-58 pancreas cancer cell line and its subline S58-SF adapted to serum-free condition derived from metastatic liver tumor.
    Takahashi N; Aoyama F; Ohuchida J; Sameshima N; Asada Y; Sawaguchi A
    Hum Cell; 2015 Oct; 28(4):190-8. PubMed ID: 26141632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.
    Kijima H; Yamazaki H; Nakamura M; Scanlon KJ; Osamura RY; Ueyama Y
    Int J Oncol; 2004 Mar; 24(3):559-64. PubMed ID: 14767540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis.
    Fujimoto K; Hosotani R; Wada M; Lee JU; Koshiba T; Miyamoto Y; Tsuji S; Nakajima S; Doi R; Imamura M
    Eur J Cancer; 1998 Aug; 34(9):1439-47. PubMed ID: 9849429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis.
    Bloomston M; Shafii A; Zervos EE; Rosemurgy AS
    J Surg Res; 2002 Jan; 102(1):39-44. PubMed ID: 11792150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new peritoneal dissemination model established from the human pancreatic cancer cell line.
    Nishimori H; Yasoshima T; Denno R; Shishido T; Hata F; Honma T; Ura H; Yamaguchi K; Yagihashi A; Tanaka H; Kawaguchi S; Kamiguchi K; Isomura H; Sato N; Hirata K
    Pancreas; 2001 May; 22(4):348-56. PubMed ID: 11345134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a new cell line derived from a human primary breast carcinoma.
    Wang CS; Goulet F; Lavoie J; Drouin R; Auger F; Champetier S; Germain L; Têtu B
    Cancer Genet Cytogenet; 2000 Jul; 120(1):58-72. PubMed ID: 10913678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis.
    Schwarte-Waldhoff I; Volpert OV; Bouck NP; Sipos B; Hahn SA; Klein-Scory S; Lüttges J; Klöppel G; Graeven U; Eilert-Micus C; Hintelmann A; Schmiegel W
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9624-9. PubMed ID: 10944227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
    Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D
    Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.